Philippe Delagrange

10.2k total citations · 1 hit paper
193 papers, 8.1k citations indexed

About

Philippe Delagrange is a scholar working on Endocrine and Autonomic Systems, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Philippe Delagrange has authored 193 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Endocrine and Autonomic Systems, 66 papers in Molecular Biology and 62 papers in Cellular and Molecular Neuroscience. Recurrent topics in Philippe Delagrange's work include Circadian rhythm and melatonin (134 papers), Receptor Mechanisms and Signaling (44 papers) and Free Radicals and Antioxidants (36 papers). Philippe Delagrange is often cited by papers focused on Circadian rhythm and melatonin (134 papers), Receptor Mechanisms and Signaling (44 papers) and Free Radicals and Antioxidants (36 papers). Philippe Delagrange collaborates with scholars based in France, United Kingdom and United States. Philippe Delagrange's co-authors include Jean A. Boutin, Ralf Jockers, Gilles Ferry, Pierre Renard, Margarita L. Dubocovich, Béatrice Guardiola‐Lemaître, Valérie Audinot, Olivier Nosjean, Emmanuel Canet and David Sugden and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The EMBO Journal.

In The Last Decade

Philippe Delagrange

190 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Update on melatonin receptors: IUPHAR Review 20

2016 321 citations Ralf Jockers, Philippe Delagrange et al. British Journal of Pharmacology profile →

Peers

Countries citing papers authored by Philippe Delagrange

Since Specialization

Citations

This map shows the geographic impact of Philippe Delagrange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Delagrange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Delagrange more than expected).

Fields of papers citing papers by Philippe Delagrange

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Delagrange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Delagrange. The network helps show where Philippe Delagrange may publish in the future.

Co-authorship network of co-authors of Philippe Delagrange

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Delagrange. A scholar is included among the top collaborators of Philippe Delagrange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Delagrange. Philippe Delagrange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glucagon receptor family in GtoPdb v.2025.3 2025 ·IUPHAR/BPS Guide to Pharmacology CITE ·D. Bataille, Roberto Salvatori, Laurence J. Miller, Kelly E. Mayo, Rebecca Hills, Burkhard Göke, Daniel J. Drucker, Philippe Delagrange, Susan L.F. Chan, Bernard Thorens	0
2	Glucagon receptor family in GtoPdb v.2023.1 2023 ·IUPHAR/BPS Guide to Pharmacology CITE ·D. Bataille, Susan L.F. Chan, Philippe Delagrange, Daniel J. Drucker, Burkhard Göke, Rebecca Hills, Kelly E. Mayo, Laurence J. Miller, Roberto Salvatori, Bernard Thorens	2
3	A Putative New Melatonin Binding Site in Sheep Brain, MTx: Preliminary Observations and Characteristics 2021 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Anne Bonnaud, Benoît Malpaux, Philippe Delagrange, Valérie Audinot, Saı̈d Yous, Jean A. Boutin, Jean-Philippe Stéphan, Jérôme Leprince, Céline Legros	4
4	Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine 2020 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Daniel H. Caignard, Philippe Delagrange, Patricia Melnyk, Saı̈d Yous	12
5	Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands 2018 ·Journal of Medicinal Chemistry ·Silvia Rivara, Laura Scalvini, Alessio Lodola, Marco Mor, (unknown), Philippe Delagrange, Simona Collina, Valeria Lucini, Francesco Scaglione, (unknown), Michele Mari, Simone Lucarini, Annalida Bedini, Gilberto Spadoni	18
6	Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT 1 /MT 2 ) and serotoninergic (5-HT 2C ) dual ligands 2017 ·European Journal of Medicinal Chemistry ·(unknown), Marouan Rami, (unknown), (unknown), Daniel‐Henri Caignard, Philippe Delagrange, Patricia Melnyk, Saı̈d Yous	13
7	Design, synthesis and biological evaluation of fluorescent ligands for MT1 and/or MT2 melatonin receptors 2016 ·SPIRE - Sciences Po Institutional REpository ·Guillaume Viault, (unknown), (unknown), Christine Lagaraine, (unknown), François Lefoulon, Véronique Bozon, Laurence Dufourny, Philippe Delagrange, Gérald Guillaumet, Franck Suzenet	1
8	Daily variation in the electrophysiological activity of mouse medial habenula neurones 2013 ·The Journal of Physiology ·(unknown), Mino D. C. Belle, Nicole Gossan, Philippe Delagrange, Hugh D. Piggins	42
9	Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration 2011 ·Molecular Psychiatry ·Therése Eriksson, Philippe Delagrange, Michael Spedding, Maurizio Popoli, Aleksander A. Mathé, Sven Ove Ögren, Per Svenningsson	61
10	Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation 2008 ·Neuropharmacology ·Hongshi Qi, François Mailliet, Michael Spedding, Cyril Rocher, Xiaoqun Zhang, Philippe Delagrange, Bruce S. McEwen, Thérèse M. Jay, Per Svenningsson	78
11	Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? 2008 ·British Journal of Pharmacology ·Ralf Jockers, Pascal Maurice, Jean A. Boutin, Philippe Delagrange	234
12	First evidence of melatonin receptors distribution in the suprachiasmatic nucleus of tree shrew brain. 2007 ·PubMed ·Céline Legros, (unknown), C. Gabriel, Elisabeth Mocaër, Philippe Delagrange, Eberhard Fuchs, Benoît Malpaux	8
13	Are G Protein‐Coupled Receptor Heterodimers of Physiological Relevance?—Focus on Melatonin Receptors 2006 ·Chronobiology International ·Angélique Levoye, Ralf Jockers, Mohammed Akli Ayoub, Philippe Delagrange, Egemen Savaskan, Jean‐Luc Guillaume	42
14	Melatonin Reduces Body Weight Gain in Sprague Dawley Rats with Diet-Induced Obesity 2003 ·Endocrinology ·Bénédicte Prunet‐Marcassus, (unknown), (unknown), Katie Louche, Philippe Delagrange, Pierre Renard, Louis Casteilla, Luc Pénicaud	234
15	New selective ligands of human cloned melatonin MT1 and MT2 receptors 2003 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Valérie Audinot, François Mailliet, (unknown), Anne Bonnaud, (unknown), (unknown), Sandra Dromaint, Marianne Rodriguez, Nadine Nagel, Jean‐Pierre Galizzi, Benoît Malpaux, Gérald Guillaumet, Daniel Lesieur, François Lefoulon, Pierre Renard, Philippe Delagrange, Jean A. Boutin	216
16	Melatonin generates an outward potassium current in rat suprachiasmatic nucleus neurones in vitro independent of their circadian rhythm 2001 ·Neuroscience ·M. van den Top, Ruud M. Buijs, Jan M. Ruijter, Philippe Delagrange, David Spanswick, Michael Hermes	72
17	Reentrainment of the spontaneous locomotor activity rhythm to a daylight reversal in C57BL/6 and C3H/He mice 2000 ·Physiology & Behavior ·Caroline Kopp, Elise Vogel, Marie‐Claire Rettori, Philippe Delagrange, René Misslin	10
18	Antagonistic Effects of S 22153, a New mt1 and MT2 Receptor Ligand, on the Neophobia-Reducing Properties of Melatonin in BALB/c Mice 1999 ·Pharmacology Biochemistry and Behavior ·Caroline Kopp, Elise Vogel, Marie‐Claire Rettori, Philippe Delagrange, Pierre‐Yves Renard, Daniel Lesieur, René Misslin	24
19	Effects of melatonin receptor ligands on swim test immobility 1998 ·Neuroreport ·David H. Overstreet, Olgierd Puciłowski, (unknown), Philippe Delagrange, Béatrice Guardiola‐Lemaître	64
20	Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats 1997 ·British Journal of Pharmacology ·Kang‐Nee Ting, William Dunn, D.J.G. Davies, David Sugden, Philippe Delagrange, Béatrice Guardiola‐Lemaître, Elizabeth Scalbert, V.G. Wilson	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact